SCOPUS 정보 검색 플랫폼

Volumn 14, Issue 11, 2000, Pages 1583-1589

Cerebrospinal fluid HIV-1 RNA during treatment with ritonavir/saquinavir or ritonavir/saquinavir/stavudine

(8) Gisolf, Elisabeth H a Enting, Roelien H a Jurriaans, Suzanne a De Wolf, Frank a Van Der Ende, Marchina E b Hoetelmans, Richard M W c Portegies, Peter a Danner, Sven A a

a ACADEMIC MEDICAL CENTER (Netherlands)

b ERASMUS MEDICAL CENTER (Netherlands)

c SLOTERVAART HOSPITAL (Netherlands)

Author keywords

Cerebrospinal fluid; HIV 1 RNA; Protease inhibitors; Stavudine

Indexed keywords

RITONAVIR; SAQUINAVIR; STAVUDINE; VIRUS RNA;

ADULT; AGED; ANTIVIRAL ACTIVITY; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CEREBROSPINAL FLUID LEVEL; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VIREMIA;

ADULT; AGED; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; REVERSE TRANSCRIPTASE INHIBITORS; RITONAVIR; RNA, VIRAL; SAQUINAVIR; STAVUDINE; TIME FACTORS;

EID: 0033815866 PISSN: 02699370 EISSN: None Source Type: Journal
DOI: 10.1097/00002030-200007280-00014 Document Type: Article

Times cited : (64)

References (19)

1
- 1842296349
- Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection
- (1997) Ann Intern Med , vol.126 , pp. 946-954
- Mellors, J.W.¹ Munoz, A.² Giorgi, J.V.³

2
- 0007010412
- Antiretroviral therapy for HIV infection in 1998. Updated recommendations of the International AIDS Society - USA panel
- (1998) JAMA , vol.280 , pp. 78-86
- Carpenter, C.C.J.¹ Fischl, M.A.² Hammer, S.M.³

3
- 0032971472
- Ritonavir and saquinavir combination therapy for the treatment of HIV infection
- (1999) AIDS , vol.13 , pp. 213-224
- Cameron, D.W.¹ Japour, A.J.² Xu, Y.³

4
- 0032122490
- Cellular and anatomical reservoirs of HIV-1 in patients receiving potent antiretroviral combination therapy
- (1998) JAMA , vol.280 , pp. 67-71
- Schrager, L.K.¹ D'Souza, R.²

5
- 0032558813
- Antiretroviral drugs and the central nervous system
- (1998) AIDS , vol.12 , pp. 1941-1955
- Enting, R.H.¹ Hoetelmans, R.M.W.² Lange, J.M.A.³ Burger, D.M.⁴ Beijnen, J.H.⁵ Portegies, P.⁶

6
- 0034077203
- Treatment with ritonavir/ saquinavir or ritonavir/saquinavir/stavudine in HIV-1 infected individuals. The effect of treatment intensification
- (2000) AIDS , vol.14 , pp. 405-413
- Gisolf, E.H.¹ Jurriaans, S.² Pelgrom, J.³

7
- 0032559406
- High-performance liquid chromatography of ritonavir in human plasma, saliva and cerebrospinal fluid
- (1998) J Chromatogr B , vol.705 , pp. 119-126
- Hoetelmans, R.M.W.¹ Van Essenberg, M.² Profijt, M.³ Meenhorst, P.L.⁴ Mulder, J.W.⁵ Beijnen, J.H.⁶

8
- 0030820242
- Determination of saquinavir in human plasma, saliva and cerebrospinal fluid by ion-pair high-performance liquid chromatography with ultraviolet detection
- (1997) J Chromatogr B , vol.698 , pp. 235-241
- Hoetelmans, R.M.W.¹ Van Essenberg, M.² Meenhorst, P.L.³ Mulder, J.W.⁴ Beijnen, J.H.⁵

9
- 0026469131
- Determination of stavudine, a new antiretroviral agent, in human plasma by reversed-phase high-performance liquid chromatography with ultraviolet detection
- (1992) J Chromatogr B Biomed Sci Appl , vol.584 , pp. 239-247
- Burger, D.M.¹ Rosins, H.² Van Gijn, R.³ Meenhorst, P.L.⁴ Van Tellingen, O.⁵ Beijnen, J.H.⁶

10
- 0028806725
- A preliminary study of ritonavir, an inhibitor of HIV-1 protease, to treat HIV-1 infection
- (1995) N Engl J Med , vol.333 , pp. 1534-1539
- Markowitz, M.¹ Saag, M.² Powderly, W.G.³

11
- 0007991335
- Plasma concentrations of saquinavir determine HIV-1 RNA response over a 48-week period. 12th World AIDS Conference. Geneva, 28 June-3 July 1998
- (1998) , pp. 825
- Hoetelmans, R.M.W.¹ Van Heeswijk, R.P.G.² Meenhorst, P.L.³ Mulder, F.W.⁴ Scheele, W.A.⁵ Beijnen, F.H.⁶

12
- 0007993044
- Self reported adherence to ritonavir/saquinavir and ritonavir/saquinavir/stavudine in a randomized clinical trial: Preliminary results. 12th World AIDS Conference. Geneva, 28 June-3 July, 1998
- (1998) , pp. 594
- Nieuwkerk, P.¹ Gisolf, E.H.² Van Leeuwen, R.³ Danner, S.A.⁴ De Boer, J.B.⁵ Sprangers, M.A.G.⁶

13
- 0007991943
- Evidence for independent development of reverse transcriptase resistance patterns in cerebrospinal fluid compartment. 12th World AIDS Conference. Geneva 1998
- (1998) , pp. 577
- Cunningham, P.¹ Smith, D.² Satchell, C.³ Cooper, D.A.⁴ Brew, B.J.⁵

14
- 0032540001
- HIV-1 protease inhibitors are substrates for the MDR1 multidrug transporter
- (1998) Biochemistry , vol.37 , pp. 3594-3601
- Lee, C.G.L.¹ Gottesman, M.M.² Cardarelli, C.O.³

15
- 0032560373
- Cerebrospinal fluid (CSF) HIV-1 RNA and drug concentrations during treatment with lamivudine (3TC) in combination with zidovudine (AZT) or stavudine (d4T)
- (1998) Lancet , vol.351 , pp. 1547-1551
- Foudraine, N.¹ Hoetelmans, R.² Lange, J.M.A.³

16
- 0007992423
- More than 2 months of an aggressive 4-drug antiretroviral regimen is required to suppress CSF HIV viral burden in previously antiretroviral naive patients. 6th Conference on Retroviruses and Opportunistic Infections. Chicago, 31 January-4 February 1999
- (1999)
- Polis, M.¹ Yoder, C.² Mican, J.³

17
- 0030728705
- Measuring the 'viral load' in cerebrospinal fluid in human immunodeficiency virus infection: Window into brain infection?
- (1997) Ann Neurol , vol.42 , pp. 675-678
- Price, R.W.¹

18
- 15144357022
- The duration of viral suppression during protease inhibitor therapy for HIV-1 infection is predicted by plasma HIV-1 RNA at nadir
- (1998) AIDS , vol.12
- Kempf, D.J.¹ Rode, R.A.² Xu, Y.³

19
- 0032814302
- Time course of cerebrospinal fluid responses to antiretroviral therapy: Evidence for variable compartmentalization of infection
- (1999) AIDS , vol.13 , pp. 1051-1061
- Staprans, S.¹ Marlowe, N.² Glidden, D.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.